Javascript must be enabled to continue!
Full Bayesian models for paired RNA-seq data and Bayesian equivalence test
View through CrossRef
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] "In my doctorate research, I have developed Bayesian models to analyze the paired RNAseq data for different types of design. The developed methods are especially of important practice for gene expression analysis using high throughput read-count data. I also proposed and studied a Bayesian test procedure for the equivalence test with parameter margin, which has a wide range of applications in pharmaceutical statistics. In the first part of my dissertation, I presented a full hierarchical Bayesian model (PairedFB) for the paired RNA-seq count data that accounts for variation of treatment effect among pairs and controls the FDR through the posterior expected FDR. The approach was shown to be able to control FDR at nominal levels and obtain slightly higher power than other methods when their actual FDRs are comparable. The real data analysis also indicates the model tends to find more biologically significant genes. In the second part of my dissertation, I extended the Bayesian model in the first part to the differential expression analysis under multiple conditions (e.g., time points, genotype, etc.). Specifically, I developed a Bayesian partitioning model that jointly models all the possible combinations of gene expression status with the use of the "inverse moment nonlocal prior". Furthermore, I modified the posterior expected FDR under the multiple groups situation so that FDR could be controlled for each group of gene expression patterns. I demonstrated that the proposed model is capable of controlling FDR under nominal levels for each combination of expression patterns, and obtaining satisfactory power even when equivalent expression testing is involved. In the last part of my dissertation, I proposed a Bayesian approach to perform the equivalence test with parameter margin. The properties of posterior distribution of parameter of interest were studied and its frequentist properties were evaluated in terms of type I error and power comparing with other frequentist methods. The developed Bayesian test procedure was shown to control type I error close to 5 percent and obtain higher power than currently best frequentist test. Using the example dataset, I demonstrated that the proposed Bayesian test could provide unique and intuitive post-experimental evidence of supporting one hypothesis in addition to reporting the dichotomized decision." --p. 192
Title: Full Bayesian models for paired RNA-seq data and Bayesian equivalence test
Description:
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.
] "In my doctorate research, I have developed Bayesian models to analyze the paired RNAseq data for different types of design.
The developed methods are especially of important practice for gene expression analysis using high throughput read-count data.
I also proposed and studied a Bayesian test procedure for the equivalence test with parameter margin, which has a wide range of applications in pharmaceutical statistics.
In the first part of my dissertation, I presented a full hierarchical Bayesian model (PairedFB) for the paired RNA-seq count data that accounts for variation of treatment effect among pairs and controls the FDR through the posterior expected FDR.
The approach was shown to be able to control FDR at nominal levels and obtain slightly higher power than other methods when their actual FDRs are comparable.
The real data analysis also indicates the model tends to find more biologically significant genes.
In the second part of my dissertation, I extended the Bayesian model in the first part to the differential expression analysis under multiple conditions (e.
g.
, time points, genotype, etc.
).
Specifically, I developed a Bayesian partitioning model that jointly models all the possible combinations of gene expression status with the use of the "inverse moment nonlocal prior".
Furthermore, I modified the posterior expected FDR under the multiple groups situation so that FDR could be controlled for each group of gene expression patterns.
I demonstrated that the proposed model is capable of controlling FDR under nominal levels for each combination of expression patterns, and obtaining satisfactory power even when equivalent expression testing is involved.
In the last part of my dissertation, I proposed a Bayesian approach to perform the equivalence test with parameter margin.
The properties of posterior distribution of parameter of interest were studied and its frequentist properties were evaluated in terms of type I error and power comparing with other frequentist methods.
The developed Bayesian test procedure was shown to control type I error close to 5 percent and obtain higher power than currently best frequentist test.
Using the example dataset, I demonstrated that the proposed Bayesian test could provide unique and intuitive post-experimental evidence of supporting one hypothesis in addition to reporting the dichotomized decision.
" --p.
192.
Related Results
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Abstract P1-05-23: Utilities and challenges of RNA-Seq based expression and variant calling in a clinical setting
Abstract P1-05-23: Utilities and challenges of RNA-Seq based expression and variant calling in a clinical setting
Abstract
Introduction
Variant calling based on DNA samples has been the gold standard of clinical testing since the advent of Sanger sequencing. The u...
Abstract 2323: Deciphering RNA degradation: Insights from a comparative analysis of paired fresh frozen/FFPE total RNA-seq
Abstract 2323: Deciphering RNA degradation: Insights from a comparative analysis of paired fresh frozen/FFPE total RNA-seq
Abstract
Background: Fresh frozen (FF) and formalin-fixed paraffin-embedded (FFPE) samples are primary resources for archival tissues in cancer studies. Despite the ...
Detection of Multiple Types of Cancer Driver Mutations Using Targeted RNA Sequencing in NSCLC
Detection of Multiple Types of Cancer Driver Mutations Using Targeted RNA Sequencing in NSCLC
ABSTRACTCurrently, DNA and RNA are used separately to capture different types of gene mutations. DNA is commonly used for the detection of SNVs, indels and CNVs; RNA is used for an...
Detecting RNA–RNA interactome
Detecting RNA–RNA interactome
AbstractThe last decade has seen a robust increase in various types of novel RNA molecules and their complexity in gene regulation. RNA molecules play a critical role in cellular e...
Generating Synthetic Single Cell Data from Bulk RNA-seq Using a Pretrained Variational Autoencoder
Generating Synthetic Single Cell Data from Bulk RNA-seq Using a Pretrained Variational Autoencoder
AbstractSingle cell RNA sequencing (scRNA-seq) is a powerful approach which generates genome-wide gene expression profiles at single cell resolution. Among its many applications, i...
Abstract 4875: HIVE Proteomics: Integrated, cloud-based RNA-Seq and proteomics analysis of prostate adenocarcinoma samples
Abstract 4875: HIVE Proteomics: Integrated, cloud-based RNA-Seq and proteomics analysis of prostate adenocarcinoma samples
Abstract
Automated bottom-up proteomics workflows implemented with modern mass-spectrometry instrumentation can readily generate millions of peptide fragmentation sp...
Benchmarking Algorithms for Gene Set Scoring of Single-cell ATAC-seq Data
Benchmarking Algorithms for Gene Set Scoring of Single-cell ATAC-seq Data
AbstractGene set scoring (GSS) has been routinely conducted for gene expression analysis of bulk or single-cell RNA-seq data, which helps to decipher single-cell heterogeneity and ...

